ArticleBriefings in bioinformatics2025
BioLLMNet: enhancing RNA-interaction prediction with a specialized cross-LLM transformation network.
Article in Briefings in bioinformatics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Machine Learning for RNA-Targeting Drug Design.Journal of chemical information and modeling · 2026Review
- Large language model agents for biological intelligence across genomics, proteomics, spatial biology, and biomedicine.Briefings in bioinformatics · 2026Review
- DeepRNA-DTI: a deep learning approach for RNA-compound interaction prediction with binding site interpretability.Journal of cheminformatics · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Ribonucleic acids (RNAs) play a central role in cellular processes by interacting with proteins, small molecules, and other RNAs. Accurate prediction of these interactions is critical for understanding post-transcriptional regulation and advancing RNA-targeted therapeutics. However, existing computational methods are limited by their reliance on hand-crafted features, modality-specific architectures, and often require structural or physicochemical data, which are experimentally challenging to obtain and unavailable for many RNA molecules. These constraints hinder generalizability and fail to capture the complex, context-dependent semantics of RNA interactions. We present BioLLMNet, a unified sequence-only framework that leverages pretrained biological language models to encode rich, contextualized representations for both RNA molecules and their interacting partners, including proteins, small molecules, and other RNAs. Our key innovation is the introduction of a novel learnable gating mechanism, which dynamically computes feature-wise weights to adaptively integrate multimodal embeddings based on input context. This mechanism, proposed here for the first time in RNA interaction modeling, enables the model to emphasize the most informative features from each partner and achieves seamless fusion of heterogeneous modalities. As a result, BioLLMNet represents a unified framework and can flexibly and consistently model all three types of interaction (RNA-protein, RNA-small molecule, and RNA-RNA) within a shared architecture, eliminating the need for modality-specific designs. Comprehensive evaluations on benchmark data sets demonstrate that BioLLMNet achieves state-of-the-art performance across all three types of interaction. Our results underscore the power of language model-based representations combined with dynamic feature fusion for generalizable, modality-aware RNA interaction prediction.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.